HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.

AbstractAIM:
Clinical and capillaroscopic evaluation of an association of Ruscus aculeatus, hesperidin methylchalcone (HMC) and ascorbic acid in chronic venous insufficiency
METHODS:
A prospective, multicenter and open clinical study. Chronic venous insufficiency patients were studied using clinical, etiological, anatomical, physiological classification (CEAP) symptom scale. Symptomatology, CEAP scale, and baseline, 2-, 4-, 6- and 8-week skin capillaroscopy were assessed. Treatment consisted of two capsules per day of Ruscus aculeatus 150 mg/HMC 150 mg/ascorbic acid 100 mg during 8 weeks.
RESULTS:
A total of 124 patients were studied, 109 female (89.28%), with a mean age of 52.5 (33-80+9.8). Initial intense reports were 79% pain, 85% heaviness, 74% cramps, 82% edema, decreasing to 20%, 12%, 8% and 14%, respectively, within two weeks, and symptomatology being absent at the end of treatment. Capillaroscopy changes at treatment completion were: 98% to 20% inter-capillary fluid decrease; 80% to 20% efferent loop thickening; 5% to 2% peri-capillary bed, and 5% to 4% mega-capillaries.
CONCLUSION:
Severe symptom decrease started from the second week until there were no symptoms at the end of treatment. It is the first time morphologic changes were observed in chronic venous insufficiency through capillaroscopy following a pharmacological intervention. Capillary-level effect was proportional to symptom decrease. Improvement was seen from the second week of treatment.
AuthorsG R Aguilar Peralta, J Arévalo Gardoqui, F J Llamas Macías, V H Navarro Ceja, S A Mendoza Cisneros, C G Martínez Macías
JournalInternational angiology : a journal of the International Union of Angiology (Int Angiol) Vol. 26 Issue 4 Pg. 378-84 (Dec 2007) ISSN: 0392-9590 [Print] Italy
PMID18091707 (Publication Type: Journal Article)
Chemical References
  • Antioxidants
  • Chalcones
  • Plant Extracts
  • cyclo 3
  • hesperidin methylchalcone
  • Hesperidin
  • Ascorbic Acid
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antioxidants (therapeutic use)
  • Ascorbic Acid (therapeutic use)
  • Chalcones (therapeutic use)
  • Chronic Disease
  • Female
  • Hesperidin (analogs & derivatives, therapeutic use)
  • Humans
  • Leg (blood supply)
  • Male
  • Microscopic Angioscopy
  • Middle Aged
  • Phytotherapy
  • Plant Extracts (therapeutic use)
  • Ruscus
  • Venous Insufficiency (complications, drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: